Immunic, Inc. to Participate in Scientific and Industry Conferences in April ...
Immunic, Inc. (NASDAQ:IMUX – Get Free Report) has received a consensus rating of “Buy” from the nine brokerages that are ...
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today ...
Shares of IMUX stock opened at $1.07 on Tuesday. The firm has a market cap of $95.93 million, a price-to-earnings ratio of -0.87 and a beta of 1.89. Immunic has a 12 month low of $0.92 and a 12 ...
Immunic (IMUX – Research Report) received a Buy rating and a $1.20 price target from William Blair analyst Matt Phipps yesterday. The company’s ...
Fintel reports that on March 25, 2025, William Blair initiated coverage of Immunic (NasdaqGS:IMUX) with a Outperform ...
NEW YORK, March 3, 2025 – Immunic , Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...
Presentation Details: Hella Kohlhof, PhD., Chief Scientific Officer of Immunic, continued, "Our second poster highlights, via a series of both in vitro and in vivo experiments, evidence of the ...
Immunic, Inc. (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced ...
Plus, a first-quarter stock and bond market wrap up. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...
Immunic, Inc. (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results